Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Combined MEK1/2 and ATR inhibition promotes myeloma cell death through a STAT3-dependent mechanism in vitro and in vivo.
Journal: British journal of haematology
Published: July 09, 2024
Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cells.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: April 13, 2023
Belantamab mafodotin in patients with relapsed/refractory AL amyloidosis with myeloma.
Journal: Annals of hematology
Published: February 14, 2022
Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNF-α antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure.
Journal: medRxiv : the preprint server for health sciences
Published: June 08, 2021
Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNFα-antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure.
Journal: Journal of clinical and translational science
Published: May 13, 2021
Smoldering multiple myeloma - Past, present, and future.
Journal: Blood reviews
Published: April 28, 2021
Factors associated with bleeding events in patients on rivaroxaban for non-valvular atrial fibrillation: A real-world experience.
Journal: International journal of cardiology
Published: May 01, 2020
Myeloid Sarcomas Causing Unilateral Cranial Nerve Palsies in a Patient with Relapsed Acute Myeloblastic Leukemia.
Journal: Case reports in hematology
Published: September 04, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026